For the Inventor, By the Inventor

Enter assignee name

Toronto, Canada

Luminex Molecular Diagnostics, Inc.

USPTO Granted Patents = 18

% Expired Patents = 61.1

CIPO Patents = 2

EPO Patents = 3

Forward Citations = 78

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Daniel Fieldhouse (14 out of 14 patents)

Daniel Kobler (14 out of 14 patents)

Albert S Benight (12 out of 19 patents)

4. Vit Janota (11 out of 11 patents)

5. Richard S Bullock (11 out of 12 patents)

6. Peter V Riccelli (11 out of 11 patents)

7. Petr Pancoska (11 out of 12 patents)

8. Susan Bortolin (4 out of 6 patents)

9. Roman L Zastawny (3 out of 4 patents)

10. Frank Merante (2 out of 2 patents)

11. Michael J Lane (1 out of 11 patents)

12. Barbara Galvan-Goldman (1 out of 1 patent)

13. Margot Boszko (1 out of 1 patent)

14. Hemanshu Modi (1 out of 1 patent)

15. Richard A Janeczko (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 8624014 - Families of non-cross-hybridizing polynucleotides for use as tags and tag complements, manufacture and use thereof (2014-01-07),

2. 8008019 - Use of dual-tags for the evaluation of genomic variable repeat regions (2011-08-30),

3. 7960537 - Polynucleotides for use as tags and tag complements, manufacture and use thereof (2011-06-14),

4. 7943322 - Polynucleotides for use as tags and tag complements, manufacture and use thereof (2011-05-17),

5. 7927809 - Polynucleotides for use as tags and tag complements, manufacture and use thereof (2011-04-19),

6. 7927808 - Polynucleotides for use as tags and tag complements, manufacture and use thereof (2011-04-19),

7. 7914997 - Polynucleotides for use as tags and tag complements, manufacture and use thereof (2011-03-29),

8. 7914989 - Capture moieties for nucleic acids and uses thereof (2011-03-29),

9. 7879543 - Method of detecting mutations associated with thrombosis (2011-02-01),

10. 7846734 - Polynucleotides for use as tags and tag complements, manufacture and use thereof (2010-12-07),

11. 7846670 - Polynucleotides for use as tags and tag complements, manufacture and use thereof (2010-12-07),

12. 7846669 - Polynucleotides for use as tags and tag complements, manufacture and use thereof (2010-12-07),

13. 7846668 - Polynucleotides for use as tags and tag complements, manufacture and use thereof (2010-12-07),

14. 7645868 - Families of non-cross-hybridizing polynucleotides for use as tags and tag complements, manufacture and use thereof (2010-01-12),

15. 7608398 - Polynucleotides for use tags and tag complements, manufacture and use thereof (2009-10-27),

Company Overview

Luminex Molecular Diagnostics, Inc. is a biotechnology company based in Toronto, Canada, specializing in the development and manufacturing of innovative molecular diagnostic solutions. The organization focuses on enhancing patient care through advanced technologies that enable the detection and analysis of genetic material. Luminex's expertise spans various applications, including infectious disease testing, genetic testing, and personalized medicine, positioning it as a key player in the molecular diagnostics landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

18 Patents

#92 in Toronto

#822 in Canada

#34,244 in the World

Toronto, Canada

Luminex Molecular Diagnostics, Inc.

Forward Citations = 78

16 inventors:

Daniel Fieldhouse (14 out of 14 patents)

Daniel Kobler (14 out of 14 patents)

Albert S Benight (12 out of 19 patents)

4. Vit Janota (11 out of 11 patents)

5. Richard S Bullock (11 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Luminex Molecular Diagnostics, Inc.. Retrieved from https://idiyas.com/company/luminex-molecular-diagnostics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…